AKX-30615-23615
3 vaccinations
1 coded response
8 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 949 / CA
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-28
Dose 1 — Pfizer-BioNTech
-
2021-03-21
Registered in v-safe
-
2021-03-21
Dose 2 — Pfizer-BioNTech
-
2021-03-21
Survey response — day 0, dose 2MedDRA: Dizziness — Feeling: Fair · Site: Pain · Chills, Fatigue or tirednessFree text: LightheadedMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-23
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tiredness, Rash, not including the immediate area around the injection site · Be unable to workAdult check-in
- 2021-03-23
- 2021-03-26
- 2021-03-27
- 2021-03-30
-
2021-09-30
Dose 3 — Pfizer-BioNTech
- 2021-10-03
- 2021-10-06
- 2021-10-07
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-28 | Pfizer-BioNTech | |
| 2 | 2021-03-21 | Pfizer-BioNTech | |
| 3 | 2021-09-30 | Pfizer-BioNTech | No |
Call center
1 call center case
1 priority 2/3 (triaged and no follow up)
Free text
Release 6 — day 0, dose 2
Systemic reaction (other): Lightheaded
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Dizziness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release